Results
1 -
10 of
15Current and future pharmacological therapies for NAFLD/NASH, Journal of Gastroenterology Special Lecture: Anti-apoptotic intervention as a novel treatment option in liver diseases, Disease Progression and Disease Prevention in Hepatology and Gastroenterology Caspases; Modulators of Apoptosis and Cytokine Maturation ? Targets for Novel Therapies, Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation, Journal of Molecular Medicine Repurposing drugs to treat neurological diseases, Journal of Neurology Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted, Cell Death & Differentiation Caspase-mediated cleavage of the centrosomal proteins during apoptosis, Cell Death & Disease The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis, Cell Death & Differentiation Combination of Emricasan with Ponatinib Synergistically Reduces Ischemia/Reperfusion Injury in Rat Brain Through Simultaneous Prevention of Apoptosis and Necroptosis, Translational Stroke Research Degradation of ??II-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions, Molecular Neurobiology